Market Tracker

02/17 5:16pm ET

Regulus Therapeutics Inc (NASDAQ:RGLS)

1.15
Delayed Data
As of Feb 17
 -0.05 / -4.17%
Today’s Change
1.05
Today|||52-Week Range
8.90
-48.89%
Year-to-Date
No recent news for Regulus Therapeutics Inc.

Today’s Trading

Previous close1.20
Today’s open1.20
Day’s range1.05 - 1.20
Volume2,019,261
Average volume (3 months)691,809
Market cap$60.9M
Dividend yield--
Data as of 3:59pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)+16.28%
Earnings growth (this year)-41.20%
Earnings growth (next 5 years)--
Revenue growth (last year)+170.69%
P/E ratioNM
Price/Sales21.60
Price/Book0.49

Competitors

 Today’s
change
Today’s
% change
CURRCure Pharmaceutical ...0.000.00%
DRNADicerna Pharmaceutic...-0.12-3.96%
NBYNovaBay Pharmaceutic...0.000.00%
TCONTRACON Pharmaceutica...-0.05-1.25%
Data as of 4:02pm ET, 02/17/2017

Financials

Next reporting dateFebruary 22, 2017
EPS forecast (this quarter)-$0.38
Annual revenue (last year)$20.8M
Annual profit (last year)-$55.7M
Net profit margin-268.55%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Paul C. Grint
COO, Principal Financial &
Accounting Officer
Joseph P. Hagan
Corporate headquarters
San Diego, California

Forecasts